Windlas Biotech
Manufacturing · India · 201-500 Employees
View Company Info for Free
Overview
Headquarters
40/1 Mohabewala Industrial Area S.b.i Ro...Phone Number
+91 1242821030Website
www.windlas.comRevenue
$79.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Windlas Biotech
Windlas Biotech Limited is a leading pharmaceutical contract manufacturer in India, specializing in high-quality and affordable pharmaceutical and nutraceutical products. The company offers a comprehensive range of contract manufacturing and research services, including customized formulations and end-to-end pharmaceutical solutions. With a strong focus on innovation, Windlas Biotech serves over 100 pharmaceutical companies across 19 countries, addressing various therapeutic areas such as anti-diabetic, cardiovascular, and respiratory health. Their mission is to advance healthcare by accelerating drug research and consistently delivering value to stakeholders.Explore more
Windlas Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Windlas Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Windlas Biotech launches new products
Click to see if Windlas Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Windlas Biotech
Check if Windlas Biotech has recently received funding, and reach out quickly before it becomes old news!
Check out if Windlas Biotech is spiking on competitors!
Windlas Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Windlas Biotech recently announced quarterly report
Funding: Get notified immidiatlly once Windlas Biotech has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Windlas Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Windlas Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Windlas Biotech.
Windlas Biotech Tech Stack
A closer look at the technologies used by Windlas Biotech
See more technologies
Most Recent Scoops
Project
A mid-level source in Infrastructure & Network Management has indicated that the organization is in the midst of initiatives related to configuration management.
Network, Infrastructure, Engineering, Product Management
Project
A mid-level source in Infrastructure & Network Management has indicated that the organization is in the midst of initiatives related to incident management. Windlas Biotech is currently evaluating vendors to support these efforts.
Network, Disaster Recovery, Information Security, Infrastructure, IoT, Security
Project
A mid-level source in Infrastructure & Network Management has indicated that the organization is in the midst of initiatives related to IT asset management. Windlas Biotech is currently evaluating vendors to support these efforts.
Network, Asset Management, Infrastructure, IoT, Enterprise Architecture
Project
A mid-level source in Infrastructure & Network Management has indicated that the organization is in the midst of initiatives related to endpoint management.
Network, Information Security, Infrastructure, Product Security, Cyber Security, Security, Threat Intelligence
Project
Implementation, Network, Servers, Infrastructure, IoT
Windlas Biotech News & Media
MATEON THERAPEUTICS AND WINDLAS BIOTECH PUBLISH PULMOHEAL™ CLINICAL DATA AGAINST COVID-19 IN PEER-REVIEWED JOURNALS
AGOURA HILLS, California, March 01, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, and Windlas Biotech Pvt. Ltd. (Windlas), a leading Indian pharmaceutical contract drug development and manufacturing organization, announced today the publication of ARTI-19 in peer-reviewed journals. ARTI-19 is “A Prospective, Randomized, Multi-center, Open-label, Interventional StudyMATEON THERAPEUTICS AND WINDLAS BIOTECH LAUNCH INDIA’S FIRST COMBINED LUNG THERAPY AND AI TELEMEDICINE 360° SOLUTION TO TRANSFORM RESPIRATORY WELLNESS AT WWW.PULMOHEAL.COM
AGOURA HILLS, California, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health and Windlas Biotech Pvt. Ltd. (Windlas), a leading Indian pharmaceutical contract drug development and manufacturing organization, announced today the launch in India of PulmoHeal™ a first-of-its-kind integrated, consumer-centric solution for respiratory wellness.Russell Finex Industrial Gyratory Sifters for Screening Pharmaceutical Powders
The Russell Eco Separator® delivers high-performance separation of various pharmaceutical powders at Windlas Biotech. [PR.com]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Windlas Biotech
Sign Up For FreeTo access detailed company insights
Windlas Biotech Limited is a leading pharmaceutical contract manufacturer in India, specializing in high-quality and affordable pharmaceutical and nutraceutical products. The company offers a comprehensive range of contract manufacturing and research services, including customized formulations and end-to-end pharmaceutical solutions. With a strong... Read More
